|
Real-time Estimate
Cboe BZX
10:07:28 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 6.355 USD | -0.39% |
|
+2.67% | -38.82% |
| 08-27 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-13 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 7.1 | 8.69 | 13.23 |
| Spread/Res. | -7.89% | -24.74% | -50.57% |
| Spread/Supp. | +12.37% | +21.11% | +46.64% |
| Support | 5.82 | 5.4 | 4.46 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CV Stock
- Charts CapsoVision, Inc.
Select your edition
All financial news and data tailored to specific country editions
